hexamethylene bisacetamide has been researched along with bryostatin 1 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blumberg, PM; Dell'Aquila, ML; Herald, CL; Nguyen, HT; Pettit, GR | 1 |
Grant, S; Jarvis, WD; Rao, AS; Vrana, JA; Wang, Z | 1 |
Barat, C; Dental, C; Ouellet, M; Proust, A; Tremblay, MJ | 1 |
3 other study(ies) available for hexamethylene bisacetamide and bryostatin 1
Article | Year |
---|---|
Inhibition by bryostatin 1 of the phorbol ester-induced blockage of differentiation in hexamethylene bisacetamide-treated Friend erythroleukemia cells.
Topics: Acetamides; Animals; Antineoplastic Agents; Bryostatins; Carcinogens; Cell Differentiation; Cell Line; Humans; Kinetics; Lactones; Leukemia, Erythroblastic, Acute; Leukemia, Experimental; Macrolides; Mice; Phorbol 12,13-Dibutyrate; Phorbol Esters | 1987 |
Effects of bryostatin 1 and calcium ionophore (A23187) on apoptosis and differentiation in human myeloid leukemia cells (HL-60) following 1-beta-D-arabinofuranosylcytosine exposure.
Topics: Acetamides; Antineoplastic Agents; Apoptosis; Bryostatins; Calcimycin; Calcium; Cell Differentiation; Cytarabine; DNA Fragmentation; HL-60 Cells; Humans; Lactones; Macrolides; Tetradecanoylphorbol Acetate | 1998 |
HIV-1 Latency-Reversing Agents Prostratin and Bryostatin-1 Induce Blood-Brain Barrier Disruption/Inflammation and Modulate Leukocyte Adhesion/Transmigration.
Topics: Acetamides; Azacitidine; Azepines; Blood-Brain Barrier; Bryostatins; Cell Adhesion; Cell Adhesion Molecules; Cell Movement; Cells, Cultured; Chemokine CCL2; Cytokines; Decitabine; HIV-1; Humans; Inflammation; Intercellular Adhesion Molecule-1; Leukocytes; Phorbol Esters; Quinazolines; Receptors, Cell Surface; Virus Latency | 2017 |